Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 67319 

Steering Committee, which are 

comprised of a broad coalition of 

organizational representatives who are 

experts in disease prevention and 

women’s health issues. With oversight 

by the Advisory Panel, and with input 

from the Multidisciplinary Steering 

Committee, WPSI examines the 

evidence to develop new (and update 

existing) recommendations for women’s 

preventive services. WPSI’s 

Dissemination and Implementation 

Steering Committee takes HRSAapproved recommendations and 

disseminates them through the 

development of implementation tools 

and resources for both patients and 

practitioners. 

WPSI bases its recommended updates 

to the Guidelines on review and 

synthesis of existing clinical guidelines 

and new scientific evidence, following 

the National Academy of Medicine 

standards for establishing foundations 

for and rating strengths of 

recommendations, articulation of 

recommendations, and external reviews. 

Additionally, HRSA requires that WPSI 

incorporate processes to assure 

opportunity for public comment, 

including participation by patients and 

consumers, in the development of its 

recommendations to the updated 

Guidelines. 

The Existing Guideline States 

‘‘Screening for Urinary Incontinence 

WPSI recommends screening women 

for urinary incontinence annually. 

Screening should ideally assess whether 

women experience urinary incontinence 

and whether it impacts their activities 

and quality of life. The Women’s 

Preventive Services Initiative 

recommends referring women for 

further evaluation and treatment if 

indicated.’’ 

Draft Updated Clinical 

Recommendation for Public Comment 

‘‘Screening for Urinary Incontinence 

The Women’s Preventive Services 

Initiative recommends screening women 

for urinary incontinence annually. 

Screening should assess whether 

women experience urinary incontinence 

and whether it impacts their activities 

and quality of life. If indicated, 

facilitating further evaluation and 

treatment is recommended.’’ 

Discussion of Draft Updated Clinical 

Recommendation 

WPSI recommended several minor 

updates to the language of this 

Guideline. First, the word ‘‘ideally’’ is 

recommended to be removed from the 

second sentence for brevity, and its 

removal, if accepted by HRSA, will not 

substantively change the existing 

guideline. Second, the final sentence of 

the clinical recommendation 

recommends changing the word 

‘‘referring’’ to ‘‘facilitating’’ to reflect 

that clinicians in practice, after 

screening for urinary incontinence, may 

decide to treat or manage urinary 

incontinence as part of standard 

primary care services or refer to 

specialists if specialist care is needed. 

Lastly, WPSI recommended minor edits 

to the language of the Guideline for the 

purposes of clarity. These minor edits 

have no substantive effect on the 

requirement for coverage without costsharing. 

Members of the public can view the 

complete updated draft 

recommendation, which includes the 

implementation considerations and 

research recommendations, by accessing 

the initiative’s web page at https:// 

www.womenspreventivehealth.org/. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–21514 Filed 9–28–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; Mentored Clinical 

Scientist Research Career Development 

Award (K08/K23) and Conference Grant 

(R13) Applications. 

Date: October 26, 2023. 

Time: 12:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Eye Institute, 6700 

Rockledge Drive, Bethesda, MD 20817 

(Virtual Meeting). 

Contact Person: Brian Hoshaw, Ph.D., 

Designated Federal Official, Division of 

Extramural Research, National Eye Institute, 

National Institutes of Health, 6700 B 

Rockledge Dr., Rockville, MD 20892, 301– 

451–2020, hoshawb@mail.nih.gov. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; Pathways to 

Independence (K99) Applications. 

Date: November 6, 2023. 

Time: 11:00 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Eye Institute, 6700B 

Rockledge Drive, Bethesda, MD 20817 

(Virtual Meeting). 

Contact Person: Ashley Fortress, Ph.D., 

Designated Federal Official, Division of 

Extramural Activities, National Eye Institute, 

National Institutes of Health, 6700 B 

Rockledge Dr., Bethesda, MD 20817, (301) 

451–2020, ashley.fortress@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: September 25, 2023. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21490 Filed 9–28–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Nursing Research; 

Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council for Nursing Research. 

This will be a hybrid meeting held inperson and virtually and will be open to 

the public as indicated below. 

Individuals who plan to attend inperson or view the virtual meeting and 

need special assistance or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The meeting 

can be accessed from the NIH Videocast 

at the following link: https://

videocast.nih.gov/ 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Nursing Research. 


lotter on DSK11XQN23PROD with NOTICES1
67320 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 

Date: January 25, 2024. 

Open: 9:00 a.m. to 3:00 p.m. 

Agenda: Call to Order and Opening 

Remarks, NINR Director’s Report, Concepts, 

Council Open Discussion. 

Place: National Institutes of Health, 

Building 31, C-Wing, Sixth Floor, Rooms 

A&B, 31 Center Drive, Bethesda, MD 20892 

(Hybrid Meeting). 

Closed: 3:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, C-Wing, Sixth Floor, Rooms 

A&B, 31 Center Drive, Bethesda, MD 20892. 

Contact Person: Elizabeth Tarlov, Ph.D., 

RN, Director, Division of Extramural Science 

Programs (DESP), National Institute of 

Nursing Research, Bethesda, MD 20892, (301) 

594–1580, elizabeth.tarlov@nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of an organization may 

submit a letter of intent, a brief description 

of the organization represented and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and 

presentations may be limited to five minutes. 

Both printed and electronic copies are 

requested for the record. In addition, any 

interested person may file written comments 

with the committee by forwarding the 

statement to the Contact Person listed on this 

notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.ninr.nih.gov/aboutninr/nacnr, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.361, Nursing Research, 

National Institutes of Health, HHS) 

Dated: September 25, 2023. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21433 Filed 9–28–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, NIHAI75N93023R00003: 

Pre-clinical Models of Infectious Diseases— 

Task Area C. 

Date: November 1–2, 2023. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G74, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Hailey Peterson Weerts, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G74, 

Rockville, MD 20852, (240) 669–5931, 

hailey.weerts@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: September 25, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21357 Filed 9–28–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Synthetic Nucleic Acid 

Platforms for HIV–1 (SNAPH): (R61/R33 

Clinical Trial Not Allowed). 

Date: November 21, 2023. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Barry J. Margulies, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G11, Rockville, MD 

20852, (301) 761–7956, barry.margulies@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: September 25, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21359 Filed 9–28–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Deafness and 

Other Communication Disorders 

Advisory Council. 

This is a virtual meeting and will be 

open to the public as indicated below. 

The url link to this meeting is: https:// 

www.nidcd.nih.gov/about/advisorycouncil/upcoming-meetings. Individuals 

who plan to attend and need special 

assistance, such as sign language 


lotter on DSK11XQN23PROD with NOTICES1